The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic
- 5 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (4), 612-621
- https://doi.org/10.1111/tri.13840
Abstract
The COVID‐19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in post‐kidney transplant recipients, the current pandemic has affected all aspects of transplant care, including transplant referrals and listing, organ donation rates, organ procurement and shipping, and waitlist mortality. Critical decisions were made during this period by transplant centers and individual transplant physicians taking into consideration patient safety and resource utilization. As countries have begun administering the COVID vaccines, new and important considerations pertinent to our transplant population have arisen. This comprehensive review focuses on the impact of COVID‐19 on kidney transplantation rates, mortality, policy decisions, and the clinical management of transplanted patients infected with COVID‐19.Keywords
This publication has 66 references indexed in Scilit:
- Global Transplantation COVID Report March 2020Transplantation, 2020
- COVID-19: A global transplant perspective on successfully navigating a pandemicAmerican Journal of Transplantation, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practiceClinical Transplantation, 2019
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeThe Oncologist, 2018
- Targeting JAK/STAT Signaling to Prevent Rejection After Kidney TransplantationTransplantation, 2016
- Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipientsTransplant Infectious Disease, 2012
- Outcomes Associated with Influenza Vaccination in the First Year after Kidney TransplantationClinical Journal of the American Society of Nephrology, 2011
- Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008